Financing - November 12, 2024
AstraZeneca invests USD 3.5 billion in the United States
The company has announced a capital investment in the United States focused on expanding its research and manufacturing footprint by the end of 2026.
Business article - October 20, 2024
New laboratory building inaugurated at Medicon Village
Through this investment of 12,500 square meters distributed on four levels, the conditions for continued expansion in the coming years are strengthened.
Biotech Business - October 16, 2024
Abera awarded SEK 1 million grant
Abera Bioscience has been awarded a grant from Vinnova to advance the development of its pneumococcal vaccine, Ab-01.12, towards clinical trials.
Financing - October 2, 2024
Senzime carries out a directed share issue of SEK 86 million
The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.
Financing - October 2, 2024
Sanofi invests in Vicore
Vicore Pharma Holding has announced an investment from Sanofi in Vicore through a commitment to subscribe for shares in the ongoing rights issue corresponding to a total of approximately USD 10 million.
Biotech Business - September 6, 2024
Pila Pharma raises capital for international obesity study
The company has recently raised SEK 10 million in directed issue for a novel obesity-related study. The aim is to study drug tolerance and the effects of the company’s molecule on obesity. The Phase-2a-study will be conducted over the next year and the capital raised will support the study with the objective to assess the […]
